Advocate for policies supporting appropriate access to high-quality molecular biomarker testing, adequate reimbursement, and role of laboratory professionals in care pathways.
Key Activities
Policy statements and comment letters; regulatory engagement; joint advocacy with AMP and CAP; LDT oversight advocacy; reimbursement rate engagement with CMS.